Over the past few years, a tiny – but slowly growing – number of people appeared to have had active, living, reproducing HIV completely eliminated from their bodies.

This week, a study finds that increased muscle area after starting HIV treatment may be due to fat accumulation within the muscle rather than new muscle formation.

This week, a study finds that abstinence-only programs continue to be ineffective at keeping young people from having sex, and censor valuable information on HIV prevention.

This week, a study finds that the average time it takes to for newly diagnosed patients to enter care is three months.

This week, a study review finds that early interventions in monkeys, such as broadly neutralizing antibodies, can help lead to viral suppression without treatment.

This week, a study finds that injectable cabotegravir, an investigational integrase inhibitor, is well tolerated and shows promise as pre-exposure prophylaxis (PrEP).

This week, a study finds that viral load perception may change sexual behaviors among HIV-positive men who have sex with men.

This week, a study finds a new key step in how HIV binds to CD4 cells, which could lead to the development of new HIV drugs.

PrEP (pre-exposure prophylaxis) is highly effective at preventing HIV, but uptake has been slow around the world. We asked providers and community leaders what they thought needed to happen for PrEP to reach everybody who needs it.

This week, a study finds that administering two broadly neutralizing antibodies very early on during infection helped monkeys achieve long-term viral suppression of simian HIV (SHIV).